https://www.business-standard.com/companies/news/pfizer-and-gsk-to-battle-for-share-of-new-rsv-vaccine-market-report-123061300331_1.html
0
0
6/13/23 at 8:02am
Organization
Business Standard
Author
Business Standard
43 words
0
Comments
US drugmaker Pfizers and British pharma major GSK are likely to face significant competition in the respiratory syncytial virus (RSV) vaccine market, according to a report on Tuesday
You are the first to view
Create an account
or login to join the discussion